Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 42,026 | 29,157 | 34,640 | 26,986 | 19,298 |
| Operating Income | -42,026 | -29,157 | -34,640 | -26,986 | 19,298 |
| Interest Expense | 1,316 | 1,449 | 1,618 | 1,282 | 0 |
| Other Income | 1,499 | 1,115 | 549 | -34 | -38,506 |
| Pre-tax Income | -41,843 | -29,491 | -35,709 | -28,302 | -19,208 |
| Net Income Continuous | -41,843 | -29,491 | -35,709 | -28,302 | -19,208 |
| Net Income | $-41,843 | $-29,491 | $-35,709 | $-28,302 | $-19,208 |
| EPS Basic Total Ops | -19.51 | -24.84 | -40.18 | -97.14 | -533.55 |
| EPS Basic Continuous Ops | -19.50 | -24.88 | -40.21 | -97.11 | -533.72 |
| EPS Diluted Total Ops | -19.51 | -24.84 | -40.18 | -97.14 | -533.55 |
| EPS Diluted Continuous Ops | -19.50 | -24.88 | -40.21 | -97.11 | -533.72 |
| EPS Diluted Before Non-Recurring Items | -19.51 | -24.84 | -40.18 | -97.14 | N/A |
| EBITDA(a) | $-41,637 | $-28,776 | $-34,002 | $-26,612 | $-18,959 |